Corbus Pharmaceuticals Holdings (CRBP) Net Income towards Common Stockholders Growth (3y) (2016 - 2025)
Corbus Pharmaceuticals Holdings (CRBP) Net Income towards Common Stockholders Growth (3y) (2016 - 2025) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Net Income Growth (3y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Alterity Therapeutics | 762,369.55 Bn | 762,369.51 Bn | - | - |
| 2 | Belite Bio | 55,096.00 Bn | 55,096.00 Bn | - | 84.25% |
| 3 | Quantum Biopharma | 17,755.80 Bn | 17,755.79 Bn | - | -10.84% |
| 4 | Legend Biotech | 3,486.00 Bn | 3,485.71 Bn | 242.10 Mn | 26.38% |
| 5 | Akari Therapeutics | 1,737.42 Bn | 1,737.41 Bn | - | -46.86% |
| 6 | Evaxion A | 1,551.28 Bn | 1,551.26 Bn | - | 34.98% |
| 7 | Psyence Biomedical | 227.32 Bn | 227.31 Bn | - | - |
| 8 | Vertex Pharmaceuticals | 110.84 Bn | 103.59 Bn | 2.59 Bn | 13.80% |
| 9 | Abivax | 91.71 Bn | 91.71 Bn | - | - |
| 10 | Corbus Pharmaceuticals Holdings | 135.08 Mn | 107.27 Mn | - | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Sep 30, 2025 | 28.82% |
| Jun 30, 2025 | -15.78% |
| Mar 31, 2025 | -32.42% |
| Dec 31, 2024 | 29.62% |
| Sep 30, 2024 | 28.25% |
| Jun 30, 2024 | 27.17% |
| Mar 31, 2024 | 26.25% |
| Dec 31, 2023 | 19.06% |
| Sep 30, 2023 | 32.46% |
| Jun 30, 2023 | 37.77% |
| Mar 31, 2023 | 16.57% |
| Dec 31, 2022 | 26.36% |
| Sep 30, 2022 | 30.91% |
| Jun 30, 2022 | -97.72% |
| Mar 31, 2022 | 31.23% |
| Dec 31, 2021 | 16.78% |
| Sep 30, 2021 | 1.75% |
| Jun 30, 2021 | -11.26% |
| Mar 31, 2021 | -9.75% |
| Dec 31, 2020 | -24.72% |